- 201. PANAMESINE
- (UMLS (NCI) C0663536) =Organic Chemical; Pharmacologic Substance ;
| - 251. Pancreatic Signet Ring Cell Carcinoma
- (UMLS (NCI) C1335317) Signet Ring Cell Carcinoma of Pancreas;
Signet Ring Cell Carcinoma of the Pancreas;
=Neoplastic Process |
- 202. Pancoast Syndrome
- [Destructive lesions of the thoracic inlet with involvement of the brachial and sympathetic plexus or carcinoma of the lung apex. It is characterized by pain in the shoulder region radiating toward the axilla and scapula, sensory and motor disorders and wasting of the muscles of the hand, the Bernard-Horner syndrome, and compression of the blood vessels with edema. (Jablonski's Dictionary of Syndromes and Eponymic Diseases, 2d ed) ( MSH )] (UMLS (NCI) C0030271) =Neoplastic Process ;
=lung neoplasm;
| - 252. Pancreatic Solid Pseudopapillary Carcinoma
- [A malignant neoplasm arising from the exocrine pancreas. It occurs predominantly in young women. It is characterized by the presence of extensive necrosis and hemorrhage and is composed of polyhedral cells forming solid and pseudopapillary patterns. There is morphologic evidence of perineural invasion, vascular invasion, or extensive invasion into the surrounding tissues. ( NCI )] (UMLS (NCI) C1336029) Solid Pseudopapillary Carcinoma of Pancreas;
Solid Pseudopapillary Carcinoma of the Pancreas;
=Neoplastic Process ;
|
- 203. Pancratistatin
- [A isoquinoline alkaloid from amaryllis with antineoplastic activity. ( NCI )] (UMLS (NCI) C0070005) =Organic Chemical; Pharmacologic Substance ;
| - 253. PANCREATIC STEATORRHEA
- (UMLS (ICD9CM) C0152166) =Disease or Syndrome
|
- 204. pancreas enzyme
- [enzymes produced by or extracted from the pancreas. ( CSP )] (UMLS (CSP) C0920330) Pancreatic Enzyme;
pancreatic enzymes;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance; Enzyme =enzyme;
| - 254. Pancreatic Vasoactive Intestinal Peptide Producing Neoplasm
- [A usually malignant pancreatic endocrine neoplasm secreting vasoactive intestinal peptide (VIP). It is associated with watery diarrhea, hypokalemia, and hypochlorhydria or achlorhydria. One third of cases are metastatic at the time of diagnosis. — 2005 ( NCI )] (UMLS (NCI) C1335318) Pancreatic Vasoactive Intestinal Peptide Producing Tumor;
Pancreatic VIP Producing Neoplasm;
Pancreatic VIP Producing Tumor;
Pancreatic VIPoma;
=Neoplastic Process |
- 205. pancreas grafting
- [transferring pancreatic cells or tissue, or whole pancreas, within an individual or between individuals of the same or different species; for specific pancreatic islet cells use PANCREATIC ISLET CELL TRANSPLANTATION. ( CSP )] (UMLS (NCI) C0030275) =Therapeutic or Preventive Procedure ;
=gastrointestinal transplantation;
endocrine transplantation =islets of Langerhans transplantation | - 255. Pancreatic Vein
- (UMLS (NCI) C0226743) =Body Part, Organ, or Organ Component
|
- 206. pancreas hormone
- [peptide hormones secreted into the blood by cells in the pancreatic islets: alpha cells secrete glucagon; beta cells secrete insulin; delta cells secrete somatostatin; and PP cells secrete pancreatic polypeptide. ( CSP )] (UMLS (CSP) C0030292) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone =Peptide Hormone;
=Antidiabetic Hormone;
[HS501] INSULIN;
Interacinar Cell Pancreatic Polypeptide | - 256. Pancreatico-Duodenal Vein
- (UMLS (NCI) C0226751) =Body Part, Organ, or Organ Component
|
- 207. pancreas imaging
- [ ] (UMLS (CSP) C0920628) =Diagnostic Procedure ;
| - 257. pancreatitis
- [acute or chronic inflammation of the pancreas due to autodigestion of pancreatic tissue by its own enzymes. ( CSP )] (UMLS (NCI) C0030305) =Disease or Syndrome =Diseases of pancreas;
=Pancreatitis, Acute Necrotizing;
Pancreatitis, Alcoholic;
|
- 208. pancreas imaging/visualization
- [visual display of structural or functional patterns of the pancreas as a whole or any of its parts for diagnostic evaluation or imaging of anatomical structures; includes measuring physiologic and metabolic responses to physical and chemical stimuli. ( CSP )] (UMLS (CSP) C0920368) =Diagnostic Procedure ;
=imaging/visualization/scanning;
| - 258. Pancreatoblastoma
- (UMLS (NCI) C0334489) =Neoplastic Process
|
- 209. Pancreas Part
- (UMLS (NCI) C1268125) =Body Part, Organ, or Organ Component
| - 259. pancreatoduodenectomy
- [Surgical removal of part of the pancreas, duodenum, and distal part of the bile duct. Sometimes, the lower portion of the stomach and the gallbladder are also removed. This procedure is performed for pancreatic, ampullary, duodenal and distal bile duct cancers. ( NCI )] (UMLS (CSP) C0085162) =Therapeutic or Preventive Procedure ;
|
- 210. Pancreas replaced by transplant
- (UMLS (ICD9CM) C0684250) =Finding ;
| - 260. Pancreatotomy
- [ ] (UMLS (ICD9CM) C0193596) =Therapeutic or Preventive Procedure
|
- 211. Pancreas Tail
- [The left extremity of the pancreas within the lienorenal ligament. ( NCI )] (UMLS (NCI) C0227590) =Body Part, Organ, or Organ Component
| - 261. Pancrelipase
- [A standardized enzyme concentrate containing the pancreatic enzymes, lipase, protease and amylase used in enzyme substitution therapy. Lipase, protease and amylase break down fat, protein, and starches, respectively in the small intestine, thereby promoting digestion. Pancrelipase is used to reduce malabsorption when the pancreas is unable to secrete sufficient amounts of these enzymes. ( NCI )] (UMLS (NCI) C0770343) PANCRELIPASE PREPARATION =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Enzyme =[GA500] DIGESTANTS;
lipase =PANCRELIPASE 400 MG;
PANCRELIPASE 425 MG;
PANCRELIPASE 8000 UNT;
|
- 212. pancreas visualization
- [ ] (UMLS (CSP) C0597165) =Diagnostic Procedure ;
| - 262. PANCURONIUM
- [A bis-quaternary steroid that is a competitive nicotinic antagonist. As a neuromuscular blocking agent it is more potent than CURARE but has less effect on the circulatory system and on histamine release. ( MSH )] (UMLS (NCI) C0030310) =Steroid; Pharmacologic Substance ;
=Androstanols;
[MS300] NEUROMUSCULAR BLOCKING AGENTS =2beta,16beta-Dipiperidino-5alpha-androstane-3alpha,17beta-diol Diacetate Dimethobromide;
|
- 213. Pancrease
- (UMLS (NCI) C0702058) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Enzyme
| - 263. PANCYTOPENIA
- [Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets. ( MSH )] (UMLS (ICD9CM) C0030312) =Disease or Syndrome =BLOOD DISEASE NOS;
|
- 214. PANCREAT SPHINCTEROPLAS
- [ ] (UMLS (ICD9CM) C0176920) =Therapeutic or Preventive Procedure
| - 264. pandemic
- [ ] (UMLS (CSP) C1615608) =Phenomenon or Process ;
|
- 215. PANCREAT SPHINCTEROTOM
- [ ] (UMLS (ICD9CM) C0176919) =Therapeutic or Preventive Procedure
| - 265. Panel Study
- (UMLS (NCI) C0681848) =Research Activity ;
|
- 216. Pancreatic Acinus
- (UMLS (NCI) C0227578) =Body Part, Organ, or Organ Component
| - 266. Paneth Cell
- [Epithelial cells found in the basal part of the intestinal glands (crypts of Lieberkuhn). Paneth cells synthesize and secrete lysozyme and cryptdins. (MeSH) ( NCI )] (UMLS (NCI) C0227276) =Cell
|
- 217. Pancreatic ACTH Producing Neoplasm
- [A malignant, ectopic ACTH secreting pancreatic endocrine neoplasm, associated with Cushing's syndrome. The prognosis is usually poor. ( NCI )] (UMLS (NCI) C1335300) Pancreatic ACTH Producing Tumor;
Pancreatic Adrenocorticotropic Hormone Producing Neoplasm;
Pancreatic Adrenocorticotropic Hormone Producing Tumor;
=Neoplastic Process ;
| - 267. PANHYPOPITUITARISM
- (UMLS (ICD9CM) C0242343) =Disease or Syndrome ;
|
- 218. Pancreatic Alpha Cell Adenoma
- (UMLS (NCI) C0279730) =Neoplastic Process
| - 268. panic anxiety syndrome
- [specific psychological phenomenon characterized by sudden onset of anxiety (often unrelated to objective events), accompanied by autonomic symptoms such as tachycardia, paresthesia, flushing, and sweating. ( CSP )] (UMLS (CSP) C0030319) =Mental or Behavioral Dysfunction =Anxiety Disorders;
|
- 219. Pancreatic Beta Cell Adenoma
- (UMLS (NCI) C0279719) =Neoplastic Process
| - 269. PANIC DIS W/O AGORPHOBIA
- (UMLS (ICD9CM) C0236794) =Mental or Behavioral Dysfunction
|
- 220. Pancreatic Bud
- (UMLS (NCI) C1283285) =Embryonic Structure
| - 270. Panidazole
- (UMLS (NCI) C0163142) =Organic Chemical; Pharmacologic Substance ;
|
- 221. Pancreatic Cancer Stage I
- [Cancer that is found only in the pancreas itself or has started to spread to the tissues next to the pancreas (such as the small intestine, the stomach, or the bile duct). ( NCI )] (UMLS (NCI) C1167720) Stage I Carcinoma of Pancreas;
Stage I Carcinoma of the Pancreas;
Stage I Pancreatic Cancer;
Stage I Pancreatic Carcinoma;
=Neoplastic Process | - 271. Panipenem
- (UMLS (NCI) C0207932) =Organic Chemical; Pharmacologic Substance ;
|
- 222. Pancreatic Cancer Stage II
- [Cancer that has spread to nearby organs such as the stomach, spleen, or colon but has not entered the lymph nodes. ( NCI )] (UMLS (NCI) C1167721) Stage II Carcinoma of Pancreas;
Stage II Carcinoma of the Pancreas;
Stage II Pancreatic Cancer;
Stage II Pancreatic Carcinoma;
=Neoplastic Process | - 272. panmural cystitis
- [ ] (UMLS (CSP) C0598716) =Disease or Syndrome ;
|
- 223. Pancreatic Cancer Stage III
- [Cancer of the pancreas in which the cancer has spread to the lymph nodes near the pancreas. Cancer may have spread to nearby organs. ( NCI )] (UMLS (NCI) C1167722) Stage III Carcinoma of Pancreas;
Stage III Carcinoma of the Pancreas;
Stage III Pancreatic Cancer;
Stage III Pancreatic Carcinoma;
=Neoplastic Process | - 273. panmural fibrosis of the bladder
- [ ] (UMLS (CSP) C0677051) =Disease or Syndrome
|
- 224. Pancreatic Carcinoma, Recurrent
- [The reemergence of pancreatic carcinoma after a period of remission. ( NCI )] (UMLS (NCI) C0854777) Recurrent Cancer of Pancreas;
Recurrent Cancer of the Pancreas;
Recurrent Carcinoma of Pancreas;
Recurrent Carcinoma of the Pancreas;
Recurrent Pancreatic Cancer;
Recurrent Pancreatic Carcinoma;
Relapsed Cancer of Pancreas;
Relapsed Cancer of the Pancreas;
Relapsed Carcinoma of Pancreas;
Relapsed Carcinoma of the Pancreas;
Relapsed Pancreatic Cancer;
Relapsed Pancreatic Carcinoma =Neoplastic Process | - 274. Panniculitis affecting other sites
- [ ] (UMLS (ICD9CM) C0158367) =Disease or Syndrome
|
- 225. Pancreatic Carcinoma, Resectable
- (UMLS (NCI) C0854778) Resectable Carcinoma of Pancreas;
Resectable Carcinoma of the Pancreas;
Resectable Pancreas Carcinoma;
Resectable Pancreatic Cancer;
Resectable Pancreatic Carcinoma;
=Neoplastic Process | - 275. PANNICULITIS OF NECK
- [ ] (UMLS (ICD9CM) C0263013) =Disease or Syndrome ;
|
- 226. Pancreatic Centroacinar Cell
- [A cell with a centrally placed nucleus found in the proximal portion of pancreatic intercalated duct that protrudes into the acinus. It secretes bicarbonate made in the cell by the dissociation of carbonic acid in the presence of carbonic anhydrase II. These cells are thought to act as signal transducers, influencing the degranulation of the acinar cells. ( NCI )] (UMLS (NCI) C1179160) =Cell ;
| - 276. Panniculitis Ossificans
- (UMLS (NCI) C1335319) =Disease or Syndrome
|
- 227. Pancreatic Delta Cell Adenoma
- (UMLS (NCI) C0279726) =Neoplastic Process
| - 277. Panomifene
- (UMLS (NCI) C0244902) =Organic Chemical; Pharmacologic Substance ;
|
- 228. Pancreatic Delta Cell Carcinoma
- [A malignant endocrine neoplasm arising from the delta cells of the pancreas which produce somatostatin. It displays vascular invasion and metastasizes to other anatomic sites. ( NCI )] (UMLS (NCI) C0279727) =Neoplastic Process
| - 278. PANOPHTHALMITIS
- [Acute suppurative inflammation of the inner eye with necrosis of the sclera (and sometimes the cornea) and extension of the inflammation into the orbit. Pain may be severe and the globe may rupture. In endophthalmitis the globe does not rupture. ( MSH )] (UMLS (ICD9CM) C0030332) =Disease or Syndrome =Uveitis, Suppurative;
|
- 229. Pancreatic Delta Cell Neoplasm
- [A usually malignant endocrine neoplasm arising from the delta cells of the pancreas. It may be associated with inappropriate secretion of serotonin and an associated clinical syndrome, or it may be hormonally inactive (non-functioning). ( NCI )] (UMLS (NCI) C1335301) Pancreatic Delta Cell Tumor;
=Neoplastic Process ;
| - 279. Panorex
- (UMLS (NCI) C0919250) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 230. Pancreatic Delta Cell Tumor
- [A usually malignant, somatostatin secreting endocrine neoplasm, arising from the delta cells of the pancreas. It is associated with diabetes mellitus, hypochlorhydia, gallbladder disease, diarrhea, steatorrhea, anaemia, and weight loss. ( NCI )] (UMLS (NCI) C1368041) Pancreatic Somatostatin Cell Tumor;
Pancreatic Somatostatin Producing Neoplasm;
Pancreatic Somatostatin Producing Tumor;
Pancreatic Somatostatinoma;
Somatostatinoma of Islet Cells;
Somatostatinoma of the Islet Cells =Neoplastic Process | - 280. Panretyn
- (UMLS (NCI) C1510845) =Organic Chemical; Pharmacologic Substance
|
- 231. PANCREATIC DISORDER NOS
- [ ] (UMLS (ICD9CM) C1263961) Unspecified disorder of pancreatic internal secretion =Disease or Syndrome
| - 281. Panrexin
- (UMLS (NCI) C1510846) =Organic Chemical; Pharmacologic Substance
|
- 232. Pancreatic Duct Stone
- (UMLS (NCI) C0341492) =Disease or Syndrome
| - 282. Panstrongylus
- [A genus of cone-nosed bugs of the subfamily TRIATOMINAE. Its species are vectors of TRYPANOSOMA CRUZI. ( MSH )] (UMLS (CSP) C0030334) =Invertebrate
|
- 233. pancreatic elastase
- [A protease of broad specificity, obtained from dried pancreas. Molecular weight is approximately 25,000. The enzyme breaks down elastin, the specific protein of elastic fibers, and digests other proteins such as fibrin, hemoglobin, and albumin. EC 3.4.21.36. ( MSH )] (UMLS (CSP) C0030306) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 283. PANTOPRAZOLE
- [A substituted benzimidazole and proton pump inhibitor with antacid activity. Pantoprazole is a lipophilic weak base that crosses the parietal cell membrane and enters the acidic parietal cell canaliculus where it becomes protonated, producing the active metabolite sulphenamide, which forms an irreversible covalent bond with two sites of the H+/K+-ATPase enzyme located on the gastric parietal cell, thereby inhibiting both basal and stimulated gastric acid production. ( NCI )] (UMLS (NCI) C0081876) =Organic Chemical; Pharmacologic Substance ;
=benzimidazole;
Sulfoxides;
[GA900] GASTRIC MEDICATIONS, OTHER;
=Pantoprazole Sodium;
|
- 234. pancreatic elastase II
- [ ] (UMLS (CSP) C0598349) =Amino Acid, Peptide, or Protein; Enzyme
| - 284. Pantoprazole Sodium
- (UMLS (NCI) C0795650) PANTOPRAZOLE SODIUM PREPARATION;
PANTOPRAZOLE SODIUM UNIDENTIFIED =Organic Chemical; Pharmacologic Substance ;
=PANTOPRAZOLE;
=PANTOPRAZOLE SODIUM 40 MG |
- 235. Pancreatic Fluid
- [thick transparent fluid containing digestive enzymes secreted by the pancreas in response to food in the duodenum. ( CSP )] (UMLS (HL7) C0030296) =Body Substance =body fluid;
Gastrointestinal Tract, Pancreas;
Body Part;
| - 285. Panuramine
- (UMLS (NCI) C0070047) =Organic Chemical; Pharmacologic Substance ;
|
- 236. Pancreatic fluid
- (UMLS (HL7) C0444147) =Body Substance ;
=SpecimenEntityType;
◊ (UMLS (HL7) C1546729) Intellectual Product Specimen Source Codes; | - 286. PANUVEITIS
- [Inflammation in which both the anterior and posterior segments of the uvea are involved and a specific focus is not apparent. It is often severe and extensive and a serious threat to vision. Causes include systemic diseases such as tuberculosis, sarcoidosis, and syphilis, as well as malignancies. The intermediate segment of the eye is not involved. ( MSH )] (UMLS (ICD9CM) C0030343) =Disease or Syndrome =uveitis;
=Ophthalmia, Sympathetic;
anterior uveitis;
Posterior Uveitis;
|
- 237. Pancreatic Foamy Gland Adenocarcinoma
- (UMLS (NCI) C1335303) =Neoplastic Process ;
| - 287. Panwarfin
- (UMLS (NCI) C0699130) =Organic Chemical; Pharmacologic Substance; Hazardous or Poisonous Substance
|
- 238. Pancreatic Injury
- (UMLS (NCI) C0273163) =Injury or Poisoning
| - 288. Panzem
- (UMLS (NCI) C1135121) =Steroid; Pharmacologic Substance
|
- 239. pancreatic islet function
- [physiological activity and functions of the pancreatic islets as a whole or of any of its cells that provide for the secretion of insulin and other hormones. ( CSP )] (UMLS (CSP) C0597166) =Organ or Tissue Function ;
=endocrinology;
| - 289. PAP SMEAR (ASC-H)
- [ ] (UMLS (ICD9CM) C1455890) Papanicolaou smear of cervix with atypical squamous cells cannot exclude high grade squamous intraepithelial lesion (ASC-H);
=Disease or Syndrome |
- 240. pancreatic islet hyperplasia
- [abnormal increase in the number of otherwise normal cells in the pancreatic islet without tumor formation; it differs from hypertrophy, which is an increase in bulk without an increase in the number of cells. ( CSP )] (UMLS (CSP) C0597167) =Disease or Syndrome ;
=hyperplasia;
Endocrine Pancreas Disease | - 290. PAP SMEAR (ASC-US)
- [ ] (UMLS (ICD9CM) C1455889) Papanicolaou smear of cervix with atypical squamous cells of undetermined significance (ASC-US);
=Disease or Syndrome |
- 241. pancreatic islet neoplasm
- [new abnormal pancreatic islet cells that grow by excessive cellular division and proliferation more rapidly than normal and continue to grow after the stimuli that initiated the new growth cease. ( CSP )] (UMLS (CSP) C0597168) =Neoplastic Process ;
=Neoplasm of Pancreas;
Endocrine Pancreas Disease =gastrinoma syndrome;
| - 291. PAP SMEAR CERVIX W HGSIL
- [ ] (UMLS (ICD9CM) C1455892) Papanicolaou smear of cervix with high grade squamous intraepithelial lesion (HGSIL);
=Disease or Syndrome |
- 242. Pancreatic Mucinous Ductal Ectasia
- (UMLS (NCI) C1335310) =Disease or Syndrome
| - 292. PAP SMEAR CERVIX W LGSIL
- [ ] (UMLS (ICD9CM) C1455891) Papanicolaou smear of cervix with low grade squamous intraepithelial lesion (LGSIL);
=Disease or Syndrome |
- 243. Pancreatic Non-Hodgkin Lymphoma
- (UMLS (NCI) C1335312) Pancreatic Non-Hodgkin's Lymphoma;
Primary Pancreatic Non-Hodgkin's Lymphoma =Neoplastic Process | - 293. PAP SMR CYTOL EVID MALIG
- [ ] (UMLS (ICD9CM) C1719648) Papanicolaou smear of cervix with cytologic evidence of malignancy =Finding
|
- 244. Pancreatic Precancerous Condition
- (UMLS (NCI) C1335314) Pancreatic Premalignant Condition;
=Neoplastic Process | - 294. PAP2
- [Expressed ubiquitously by human PPAP2A Gene (PAP Family), 284-aa 32-kDa Phosphatidic Acid Phosphatase Type 2A is a type 2 integral plasma membrane glycoprotein enzyme with extracellular activity predicted to contain 6 transmembrane regions and a conserved N-glycosylation site. PPAP2A exhibits 47% sequence identity with PPAP2B and 54% identity with PPAP2C; the C-terminal 40-aa of PPAP2A, PPAP2B, and PPAP2C show greatest divergence. PPAP2A has an active role in metabolic pathways controlling synthesis of glycerophospholipids and triacylglycerols, in hydrolysis and uptake of lipids from the extracellular space, in dephosphorylation of phosphatidic acid to diacylglycerol, and in receptor-activated signal transduction mediated by phospholipase D. (NCI) ( NCI )] (UMLS (NCI) C1335404) PAP2A;
Phosphatidic Acid Phosphatase 2A;
Phosphatidic Acid Phosphatase Type 2A;
Phosphatidic Acid Phosphohydrolase Type 2A;
PPAP2A;
Type 2 Phosphatidic Acid Phosphohydrolase;
Type-2 Phosphatidic Acid Phosphatase Alpha =Amino Acid, Peptide, or Protein; Enzyme |
- 245. pancreatic ribonuclease
- [An enzyme that catalyzes the endonucleolytic cleavage of pancreatic ribonucleic acids to 3'-phosphomono- and oligonucleotides ending in cytidylic or uridylic acids with 2',3'-cyclic phosphate intermediates. EC 3.1.27.5. ( MSH )] (UMLS (CSP) C0035541) =Amino Acid, Peptide, or Protein; Enzyme ;
=Endoribonuclease;
| - 295. papain
- [A proteolytic enzyme obtained from Carica papaya. It is also the name used for a purified mixture of papain and CHYMOPAPAIN that is used as a topical enzymatic debriding agent. EC 3.4.22.2. ( MSH )] (UMLS (CSP) C0030346) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Enzyme =caspase;
Cysteine Endopeptidases;
Inactive Ingredient Preparations;
=ENZYMATIC CLEANER (PAPAIN) TAB,OPH;
PAPAIN 1.1 MILLION UNT;
PAPAIN 10000 UNT;
PAPAIN 60 MG;
PAPAIN 16.2 MG;
PAPAIN POWDER (GM);
PAPAIN 100 MG;
PAPAIN 830000 UNT;
PAPAIN 10 %;
PAPAIN 8300000 UNT |
- 246. Pancreatic Sarcoma
- (UMLS (NCI) C1096346) Sarcoma of Pancreas;
Sarcoma of the Pancreas;
=Neoplastic Process ;
| - 296. PAPAVERINE
- [opium alkaloid used as a smooth muscle relaxant and weak analgesic. ( CSP )] (UMLS (NCI) C0030350) =Organic Chemical; Pharmacologic Substance ;
=alkaloid;
2 benzazine;
Opium;
Muscle Relaxant;
[CV500] PERIPHERAL VASODILATORS;
=ethaverine;
Papaverine HCl |
- 247. Pancreatic Secretin Receptor
- [Encoded by human SCTR Gene (GPCR2 Family), 440-aa 50-kDa (precursor) 7 transmembrane integral membrane protein Secretin Receptor binds secretin and, mediated by G proteins that activate adenylyl cyclase, regulates pancreatic bicarbonate, enzyme, and potassium ion secretion. (NCI) ( NCI )] (UMLS (NCI) C0074254) =Amino Acid, Peptide, or Protein; Receptor ;
| - 297. Papaverine HCl
- (UMLS (NCI) C0700461) =Organic Chemical; Pharmacologic Substance =PAPAVERINE;
=PAPAVERINE HYDROCHLORIDE 150 MG;
PAPAVERINE HYDROCHLORIDE 30 MG/ML;
|
- 248. Pancreatic Secretory Trypsin Inhibitor
- [SPINK1 is secreted from pancreatic acinar cells into pancreatic juice and is thought to prevent trypsin-catalyzed premature activation of pancreatic zymogens. It is also found in serum and various normal tissues; SPINK1 is produced by gastrointestinal tract mucosa where it may protect mucosal cells from proteolytic breakdown. (from OMIM 167790 and NCI) ( NCI )] (UMLS (NCI) C0085741) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Biologically Active Substance
| - 298. PAPAVEROLINE
- (UMLS (NCI) C0070050) =Organic Chemical; Pharmacologic Substance ;
|
- 249. Pancreatic Serous Cystadenocarcinoma
- (UMLS (NCI) C1335315) Serous Cystadenocarcinoma of Pancreas;
Serous Cystadenocarcinoma of the Pancreas =Neoplastic Process | - 299. Paper
- (UMLS (HL7) C1547566) =Idea or Concept =Authorization Mode;
|
- 250. Pancreatic Serous Cystadenoma
- [A non-metastasizing cystic epithelial neoplasm arising from the exocrine pancreas. It is composed of glycogen-rich, ductular-type epithelial cells which produce a watery fluid. Signs and symptoms include abdominal mass, abdominal pain, nausea, vomiting, and weight loss. ( NCI )] (UMLS (NCI) C1335316) Serous Cystadenoma of Pancreas;
Serous Cystadenoma of the Pancreas;
=Neoplastic Process | - 300. paper chromatography
- [procedure for analysis of complex chemical mixtures by progressive absorption of the unknown sample in solvent on a special grade of paper. ( CSP )] (UMLS (CSP) C0008568) =Laboratory Procedure =chromatography;
|
home
